LinkedInFacebookXYouTube

RBQM

RBQM is laser-focused. Risk-based Quality Management (RBQM) considers each research program holistically, identifies areas of increased risk, and uses that information as the basis for a customized monitoring program. RBQM is not “reduced” monitoring, it is strategic monitoring based on technologically enabled, risk-based algorithms that focus monitoring resources on the locations and activities where they are most needed.

RBQM isn’t static. If risk levels increase at any phase or stage of a study, monitoring can quickly be intensified.

The power of RBQM lies in risk identification and strategic vigilance.

Jun 2019

Cyntegrity Launches MyRBQM® Portal

By |2020-09-23T10:51:07+02:00June 14, 2019|News, RBQM Product Updates|Comments Off on Cyntegrity Launches MyRBQM® Portal

MyRBQM Portal is world's first one-stop clinical trial optimization solution and opens the door to fully fledged risk-based quality management. Get your free user license today!

Read More
May 2019

Centralized Monitoring: a Greater Advantage to a Broader Range of Trials

By |2024-06-14T18:05:28+02:00May 2, 2019|Blog, Free Infographics|Comments Off on Centralized Monitoring: a Greater Advantage to a Broader Range of Trials

Regulatory bodies are unanimous, today's clinical research needs Centralized Monitoring. We summarized Centralized Monitoring the infographic way, download your free copy here...

Read More
Apr 2019

RBQM Software Features: What’s a Risk Flower chart?

By |2019-08-07T19:11:02+02:00April 9, 2019|Blog, Neat Features|1 Comment

Neat Features: wanting to dig a little deeper into the neat software features that make your risk-management life easy? Well, you’ve come to the right place. Learn more about Risk Flowers charts - a bunch of information.

Read More
Jan 2019

Quality Tolerance Limits versus Key Risk Indicators, The Difference

By |2024-06-14T14:11:24+02:00January 18, 2019|Blog, Free Infographics|1 Comment

To clear up confusion surrounding the interpretation and use of QTLs and KRIs, we have created an easy to understand infographic for all clinical research experts involved in quality control.

Read More
Jul 2018

DIA 2018 Global Annual Meeting: was this year’s theme the most dead-on yet?

By |2018-07-17T09:10:07+02:00July 16, 2018|Blog|Comments Off on DIA 2018 Global Annual Meeting: was this year’s theme the most dead-on yet?

The dramatic expansion of prescription drug deaths inspired this year's theme "driving insights to action". Insights that could be deployed through novel disruptive technologies such as Risk-based Quality Management (RBQM). Cyntegrity's Johann Proeve and Nimita Limaye were in Boston and share their observations with us.

Read More
May 2018

Key Risk Indicators Reveal Blind Spots in Clinical Trials

By |2018-05-16T09:02:30+02:00May 15, 2018|Blog|Comments Off on Key Risk Indicators Reveal Blind Spots in Clinical Trials

By design, the traditional spot-checking type of audits leave a blind spot on systemic quality threats. Key Risk Indicators however, form the core of a widely applicable concept that captures all relevant risks in scope and provides project managers and QM experts targeted and objective updates on actionable issues and trends.

Read More
Feb 2018

What is the Cost of Poor Quality in Pharma?

By |2020-09-23T09:07:14+02:00February 20, 2018|Blog, Free Infographics|Comments Off on What is the Cost of Poor Quality in Pharma?

Quality is a business decision. Everyone instinctively knows that poor quality doesn't come cheap, however until now no attempt was made to calculate the real difference between good and poor quality in clinical trials. Most of the issues that impact cost and expenses are lurking just below the tip of the iceberg.

Read More
Dec 2014

Duality of Risk-based Monitoring Definition: EMA vs FDA

By |2019-03-21T12:16:18+02:00December 9, 2014|Free White Papers|Comments Off on Duality of Risk-based Monitoring Definition: EMA vs FDA

In October 2014 at the Risk-based Monitoring conference in Copenhagen the Senior Director QA Operations of Janssen, Jan Van Parijs said: "Industry is historically heavily regulated, so as an industry we are kind of used to the fact that the authorities provide a set [...]

Read More
Go to Top